
Impel Pharmaceuticals Inc.
IMPLNASDAQHealthcare
$0.04
$-0.02(-27.27%)
Market Cap$956000
P/E Ratio—
52W High$4.2
52W Low$0.0212
Impel Pharmaceuticals Inc. (IMPL) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · IMPL · as of 2026-06-09
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|
| Assets | ||||
| Cash & ST Investments | $60.65M | $88.21M | $7.09M | $37.00M |
| Net Receivables | $7.44M | $1.35M | $0.00M | $0.00M |
| Inventory | $8.43M | $2.82M | $0.00M | $0.00M |
| Total Current Assets | $79.81M | $94.58M | $8.17M | $39.52M |
| PP&E Net | $7.00M | $3.15M | $3.70M | $2.74M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $88.55M | $97.91M | $12.06M | $42.27M |
| Liabilities | ||||
| Short-Term Debt | $1.54M | $0.00M | $0.42M | $0.00M |
| Accounts Payable | $6.09M | $6.37M | $4.31M | $2.73M |
| Total Current Liabilities | $22.16M | $15.95M | $10.53M | $8.32M |
| Long-Term Debt | $49.65M | $29.45M | $7.99M | $0.00M |
| Total Liabilities | $132.71M | $45.40M | $145.56M | $133.97M |
| Stockholders Equity | ||||
| Retained Earnings | ($321.11M) | ($214.80M) | ($138.26M) | ($92.46M) |
| Total Stockholders Equity | ($44.16M) | $52.51M | ($133.50M) | ($91.70M) |
| Total Liab & Equity(computed) | $88.55M | $97.91M | $12.06M | $42.27M |
| Debt Summary | ||||
| Total Debt | $51.19M | $29.45M | $8.41M | $0.00M |
| Net Debt | ($9.47M) | ($58.76M) | $1.32M | ($37.00M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Impel Pharmaceuticals Inc. data
About Impel Pharmaceuticals Inc. (IMPL) Balance Sheet
Impel Pharmaceuticals Inc. (IMPL) balance sheet shows total assets of $0.09B with cash of $0.06B. Total liabilities are $0.13B, total debt $0.05B, and stockholders equity ($0.04B).
Frequently asked questions
IMPL · 4 questionsImpel Pharmaceuticals Inc. has total debt of $0.05B with net debt of ($0.01B).
IMPL total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09